tradingview
Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% Stake
Kira S. Sheinerman disclosed beneficial ownership of 51.56% of Niki BioSolutions, Inc.’s common stock. The stake resulted from the July 20, 2026 merger in which Aptorum domesticated and renamed itself Niki BioSolutions, with shares issued as non-cash consideration. The position gives Sheinerman sig…